A randomized double blind phase III trial of Pazopanib v

Project: Research project

Project Details

Description

A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy
StatusFinished
Effective start/end date7/28/086/30/14

Funding

  • GlaxoSmithKline

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.